Search research articles
Contact Us
Filters
Showing results (961-970 of 1,011) with videos related to
Page
of 102
Sort By:
Blood
|
September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
David Miklos, Corey S Cutler, Mukta Arora, et al.
British Journal of Haematology
|
June 7, 2018
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials
Jeffrey Jones, Anthony Mato, Steven Coutre, et al.
Blood
|
February 14, 2018
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience
Susan O'Brien, Richard R Furman, Steven Coutre, et al.
Stem Cell Reports
|
July 4, 2020
A Highly Phenotyped Open Access Repository of Alpha-1 Antitrypsin Deficiency Pluripotent Stem Cells
Joseph E Kaserman, Killian Hurley, Mark Dodge, et al.
Blood
|
February 21, 2015
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib
John C Byrd, Richard R Furman, Steven E Coutre, et al.
Neurosurgery
|
December 3, 2020
Low-Dose Intravenous Heparin Infusion After Aneurysmal Subarachnoid Hemorrhage is Associated With Decreased Risk of Delayed Neurological Deficit and Cerebral Infarction
Matthew J Kole, Aaron P Wessell, Beatrice Ugiliweneza, et al.
British Journal of Haematology
|
April 12, 2017
Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib
Jeffrey A Jones, Peter Hillmen, Steven Coutre, et al.
Environmental Toxicology and Chemistry
|
September 18, 2007
Intra- and interlaboratory variability in acute toxicity tests with glochidia and juveniles of freshwater mussels (Unionidae)
Ning Wang, Tom Augspurger, M Chris Barnhart, et al.
The Journal of Biological Chemistry
|
November 24, 1999
Engineering a glucose-responsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy
W M MacFarlane, J C Chapman, R M Shepherd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2017
Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Steven E Coutré, Richard R Furman, Ian W Flinn, et al.
Page
of 102
Search research articles
Search
Showing results (961-970 of 1,011) with videos related to
Sort By:
Page
of 102
Blood
|
September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
David Miklos, Corey S Cutler, Mukta Arora, et al.
British Journal of Haematology
|
June 7, 2018
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials
Jeffrey Jones, Anthony Mato, Steven Coutre, et al.
Blood
|
February 14, 2018
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience
Susan O'Brien, Richard R Furman, Steven Coutre, et al.
Stem Cell Reports
|
July 4, 2020
A Highly Phenotyped Open Access Repository of Alpha-1 Antitrypsin Deficiency Pluripotent Stem Cells
Joseph E Kaserman, Killian Hurley, Mark Dodge, et al.
Blood
|
February 21, 2015
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib
John C Byrd, Richard R Furman, Steven E Coutre, et al.
Neurosurgery
|
December 3, 2020
Low-Dose Intravenous Heparin Infusion After Aneurysmal Subarachnoid Hemorrhage is Associated With Decreased Risk of Delayed Neurological Deficit and Cerebral Infarction
Matthew J Kole, Aaron P Wessell, Beatrice Ugiliweneza, et al.
British Journal of Haematology
|
April 12, 2017
Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib
Jeffrey A Jones, Peter Hillmen, Steven Coutre, et al.
Environmental Toxicology and Chemistry
|
September 18, 2007
Intra- and interlaboratory variability in acute toxicity tests with glochidia and juveniles of freshwater mussels (Unionidae)
Ning Wang, Tom Augspurger, M Chris Barnhart, et al.
The Journal of Biological Chemistry
|
November 24, 1999
Engineering a glucose-responsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy
W M MacFarlane, J C Chapman, R M Shepherd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2017
Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Steven E Coutré, Richard R Furman, Ian W Flinn, et al.
Page
of 102